Company Filing History:
2 out of 25 
2 out of 505 
Years Active: 2021-2023
Title: Max Gordon: Innovator in Cancer Treatment
Introduction
Max Gordon is a notable inventor based in Portland, OR (US), recognized for his contributions to the field of cancer treatment. With a total of 2 patents, he has made significant strides in developing diagnostic methods and treatment regimens for leukemia.
Latest Patents
Gordon's latest patents focus on assays and methods for selecting a treatment regimen for subjects with leukemia. These diagnostic methods aim to identify cancer-bearing subjects who are appropriate for treatment with CPX-351. The patents detail genetic and ex vivo testing of cells from candidate subjects. Furthermore, they explore how combination treatment with CPX-351 and FLT-3 inhibitors can improve the uptake and reduce the toxicity of CPX-351.
Career Highlights
Throughout his career, Max Gordon has worked with prominent organizations such as Celator Pharmaceuticals, Inc. and Oregon Health & Science University. His work in these institutions has allowed him to advance his research and contribute to innovative cancer therapies.
Collaborations
Gordon has collaborated with esteemed colleagues, including Paul Tardi and Jeffrey Tyner. These partnerships have fostered a collaborative environment that enhances the development of effective cancer treatment strategies.
Conclusion
Max Gordon's innovative work in the field of cancer treatment exemplifies the impact of dedicated inventors on medical advancements. His patents and collaborations continue to pave the way for improved diagnostic